BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 25613063)

  • 1. ARNT2 is downregulated and serves as a potential tumor suppressor gene in non-small cell lung cancer.
    Yang B; Yang E; Liao H; Wang Z; Den Z; Ren H
    Tumour Biol; 2015 Mar; 36(3):2111-9. PubMed ID: 25613063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of ARNT2 promotes tumor growth and predicts poor prognosis in human hepatocellular carcinoma.
    Li W; Liang Y; Yang B; Sun H; Wu W
    J Gastroenterol Hepatol; 2015 Jun; 30(6):1085-93. PubMed ID: 25611915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PEBP4 enhanced HCC827 cell proliferation and invasion ability and inhibited apoptosis.
    Yu G; Shen Z; Chen G; Teng X; Hu Y; Huang B
    Tumour Biol; 2013 Feb; 34(1):91-8. PubMed ID: 22983920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-383 is a tumor suppressor and potential prognostic biomarker in human non-small cell lung caner.
    Shang Y; Zang A; Li J; Jia Y; Li X; Zhang L; Huo R; Yang J; Feng J; Ge K; Yang Y; Zhang Y; Jiang J
    Biomed Pharmacother; 2016 Oct; 83():1175-1181. PubMed ID: 27551765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the neuroprotective protein aryl hydrocarbon receptor nuclear translocator 2 correlates with neuronal stress and disability in models of multiple sclerosis.
    Rahim T; Becquart P; Baeva ME; Quandt J
    J Neuroinflammation; 2018 Sep; 15(1):270. PubMed ID: 30231889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in chromatin state reveal ARNT2 at a node of a tumorigenic transcription factor signature driving glioblastoma cell aggressiveness.
    Bogeas A; Morvan-Dubois G; El-Habr EA; Lejeune FX; Defrance M; Narayanan A; Kuranda K; Burel-Vandenbos F; Sayd S; Delaunay V; Dubois LG; Parrinello H; Rialle S; Fabrega S; Idbaih A; Haiech J; Bièche I; Virolle T; Goodhardt M; Chneiweiss H; Junier MP
    Acta Neuropathol; 2018 Feb; 135(2):267-283. PubMed ID: 29149419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-37 suppresses tumor growth through inhibition of angiogenesis in non-small cell lung cancer.
    Ge G; Wang A; Yang J; Chen Y; Yang J; Li Y; Xue Y
    J Exp Clin Cancer Res; 2016 Jan; 35():13. PubMed ID: 26791086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of ARNT2 is associated with decreased cell proliferation and better prognosis in gastric cancer.
    Jia Y; Hao S; Jin G; Li H; Ma X; Zheng Y; Xiao D; Wang Y
    Mol Cell Biochem; 2019 Jan; 450(1-2):97-103. PubMed ID: 29948506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-770 inhibits tumorigenesis and EMT by targeting JMJD6 and regulating WNT/β-catenin pathway in non-small cell lung cancer.
    Zhang Z; Yang Y; Zhang X
    Life Sci; 2017 Nov; 188():163-171. PubMed ID: 28882645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of ARNT2 gene on invasion and migration of human hepatocellular carcinoma HCCLM6 cell line].
    Li WW; Wu WZ; Liang Y; Xiao CL; Tao ZH; Wang L; Sun HC; Fan J
    Zhonghua Gan Zang Bing Za Zhi; 2010 Jan; 18(1):27-31. PubMed ID: 20128965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C10ORF97 is a novel tumor-suppressor gene of non-small-cell lung cancer and a functional variant of this gene increases the risk of non-small-cell lung cancer.
    Shi Y; Chen J; Li Z; Zhang Z; Yu H; Sun K; Wang X; Song X; Wang Y; Zhen Y; Yang T; Lou K; Zhang Y; Zhang G; Hu Y; Ji J; Hui R
    Oncogene; 2011 Sep; 30(39):4107-17. PubMed ID: 21499297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-541-3p reverses cancer progression by directly targeting TGIF2 in non-small cell lung cancer.
    Lu YJ; Liu RY; Hu K; Wang Y
    Tumour Biol; 2016 Sep; 37(9):12685-12695. PubMed ID: 27448300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Krüppel-Like Factor 6 Downregulation Is Connected with a Poor Prognosis and Tumor Growth in Non-Small-Cell Lung Cancer.
    Zeng B; Lin J; Cai X; Che L; Zeng W; Liu S
    Comput Math Methods Med; 2022; 2022():3193553. PubMed ID: 35136416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of the epidermal growth factor receptor gene to investigate its therapeutic potential for the treatment of non-small-cell lung cancers.
    Shien K; Ueno T; Tsukuda K; Soh J; Suda K; Kubo T; Furukawa M; Muraoka T; Maki Y; Tanaka N; Yamamoto H; Kiura K; Mitsudomi T; Toyooka S; Miyoshi S
    Clin Lung Cancer; 2012 Nov; 13(6):488-93. PubMed ID: 22503506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of LATS2 in non-small cell lung cancer promoted the growth and motility of cancer cells.
    Yao F; Liu H; Li Z; Zhong C; Fang W
    Tumour Biol; 2015 Mar; 36(3):2049-57. PubMed ID: 25391426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Xenoestrogens down-regulate aryl-hydrocarbon receptor nuclear translocator 2 mRNA expression in human breast cancer cells via an estrogen receptor alpha-dependent mechanism.
    Qin XY; Zaha H; Nagano R; Yoshinaga J; Yonemoto J; Sone H
    Toxicol Lett; 2011 Oct; 206(2):152-7. PubMed ID: 21771643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of tumor inhibition and apoptosis by a candidate tumor suppressor gene DRR1 on 3p21.1.
    Liu Q; Zhao XY; Bai RZ; Liang SF; Nie CL; Yuan Z; Wang CT; Wu Y; Chen LJ; Wei YQ
    Oncol Rep; 2009 Nov; 22(5):1069-75. PubMed ID: 19787223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-186 suppresses cell proliferation and metastasis through targeting MAP3K2 in non-small cell lung cancer.
    Huang T; She K; Peng G; Wang W; Huang J; Li J; Wang Z; He J
    Int J Oncol; 2016 Oct; 49(4):1437-44. PubMed ID: 27498924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-142-3p functions as a potential tumor suppressor directly targeting HMGB1 in non-small-cell lung carcinoma.
    Xiao P; Liu WL
    Int J Clin Exp Pathol; 2015; 8(9):10800-7. PubMed ID: 26617792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Krüppel-like factor 6 is frequently down-regulated and induces apoptosis in non-small cell lung cancer cells.
    Ito G; Uchiyama M; Kondo M; Mori S; Usami N; Maeda O; Kawabe T; Hasegawa Y; Shimokata K; Sekido Y
    Cancer Res; 2004 Jun; 64(11):3838-43. PubMed ID: 15172991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.